AbbVie Inc. against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-10-13T20:04:28+00:00 UTC · updates daily
TEVA leads 4 of the 5 windows we measure — over 1 month ABBV is +6.7% and TEVA +11.2%; over year to date ABBV is +20.1% and TEVA +32.2%. The ABBV/TEVA price ratio stands at 6.6512, below its 50-day average of 6.8716, and below the 200-day average of 6.8717. A ratio above its own average means ABBV is gaining on TEVA; on this reading the recent edge belongs to TEVA.
| ABBV | TEVA | |
|---|---|---|
| Price | $274.36 | $41.25 |
| 1 day | -2.4% | +0.2%lead |
| 5 days | +2.9% | +5.4%lead |
| 1 month | +6.7% | +11.2%lead |
| 6 months | +32.9%lead | +32.4% |
| Year to date | +20.1% | +32.2%lead |
| 52-week position | 90% of range | 97% of range |
| 52-week range | $190.75–$283.31 | $18.83–$42.02 |
| vs 50-day average | above $260.08 | above $37.88 |
| vs 200-day average | above $233.14 | above $34.01 |
| RSI (14) | 63 | 66 |
| Next earnings | 2026-10-30 | 2026-11-03 |
ABBV trades at $274.36, above its 50-day average of $260.08, and above the 200-day at $233.14. It sits at 90% of its 52-week range ($190.75–$283.31); 14-day RSI is 63, in neutral territory; an average session moves it about 2.2%. For levels, the first level overhead is $275.00 (0.2% away) and the first support below is $267.02 (2.7% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA trades at $41.25, above its 50-day average of $37.88, and above the 200-day at $34.01. It sits at 97% of its 52-week range ($18.83–$42.02); 14-day RSI is 66, in neutral territory; an average session moves it about 2.9%. For levels, the first level overhead is $45.00 (9.1% away) and the first support below is $40.00 (3.0% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
TEVA is the more volatile of the two — an average session moves it 2.9% against 2.2% for ABBV, so an identical position size carries roughly 1.3× the daily risk.
The comparison turns on those levels: ABBV clearing $275.00 or losing $267.02; TEVA clearing $45.00 or losing $40.00. Until one of them gives way, the relative reading above stands.